ALEXANDRIA, Va., March 26 -- United States Patent no. 12,257,294, issued on March 25, was assigned to DANMARKS TEKNISKE UNIVERSITET (Kongens Lyngby, Denmark).
"Therapeutics for autoimmune disease: synthetic antigens" was invented by Kira Astakhova (Copenhagen SV, Denmark).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns therapeutics for autoimmune diseases and provides removal of inflammation-causing autoantibodies. In order to target the disease in the most efficient manner, a nanoconjugate complex is provided, comprising at least one specific antigen component recognized by autoantibodies related to the autoimmune disease, at least one helper moiety, and a nanoparticle carrier c...